Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Alx Oncology Holdings (ALXO) Return on Capital Employed (2020 - 2026)

Alx Oncology Holdings' Return on Capital Employed history spans 4 years, with the latest figure at 17.29% for Q4 2023.

  • On a quarterly basis, Return on Capital Employed fell 815.0% to 17.29% in Q4 2023 year-over-year; TTM through Dec 2023 was 17.29%, a 815.0% decrease, with the full-year FY2023 number at 14.16%, down 593.0% from a year prior.
  • Return on Capital Employed hit 17.29% in Q4 2023 for Alx Oncology Holdings, up from 26.76% in the prior quarter.
  • Over the last five years, Return on Capital Employed for ALXO hit a ceiling of 2.79% in Q4 2020 and a floor of 40.34% in Q3 2022.
  • Historically, Return on Capital Employed has averaged 16.89% across 4 years, with a median of 13.61% in 2023.
  • Biggest five-year swings in Return on Capital Employed: crashed -3059bps in 2022 and later soared 1885bps in 2023.
  • Tracing ALXO's Return on Capital Employed over 4 years: stood at 2.79% in 2020, then plummeted by -701bps to 22.3% in 2021, then soared by 59bps to 9.13% in 2022, then plummeted by -89bps to 17.29% in 2023.
  • Business Quant data shows Return on Capital Employed for ALXO at 17.29% in Q4 2023, 26.76% in Q3 2023, and 14.87% in Q2 2023.